"Welcome to SSJ Finance"

Profit & Loss Accounts

Quarterly Results

Ipca Laboratories Ltd
Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln	Chairman : Premchand Godha
Home : Indian Private	Book Value: 314.5139046
BSE Code : 524494	Market Cap: 46682.84
NSE Code : IPCALAB	P / E : 40.42

Change Company :

Quarters:

(Rs in Cr.)

Quarterly Results

Particulars	Mar 2026	Dec 2025	Sep 2025	Jun 2025
Type	4Qtr	3Qtr	2Qtr	1Qtr
Net Sales	1814.35	1845.18	1930.32	1746.90
Other Income	29.88	17.82	21.92	25.02
Total Income	1844.23	1863.00	1952.24	1771.92
Total Expenditure	1413.59	1367.70	1465.61	1339.98
Operating Profit	430.64	495.30	486.63	431.94
Interest	10.48	9.51	11.46	12.06
Gross Profit	420.16	485.79	475.17	419.88
Depreciation	70.31	68.57	66.86	63.13
Tax	94.11	110.83	104.52	92.66
Deferred Tax	-6.55	2.94	-0.95	2.05
Reported Profit After Tax	262.29	303.45	304.74	262.04

SSJ FINANCE & SECURITIES PRIVATE LIMITED:
1st Floor, Merchant Chamber, Opp. Patkar Hall, 41, New Marine Lines, Mumbai – 400 020
SEBI Regn. Number: INZ000178436 | CDSL: IN-DP-109-2015 | ARN: 40860 | CIN: U67120MH1996PTC104822

SSJ COMMODITIES PRIVATE LIMITED:
SEBI Regn. Number: INZ000013439 | CIN: U51909MH2003PTC140481|Research Analyst SEBI Reg. No.INH000001527

Content powered by Capital Market Charts are powered by TradingView